MAPT and Parkinson disease: In addition to AD, tau oligomers have been identified in other tauopathies including progressive supranuclear palsy (PSP) [23], Parkinson’s disease (PD), dementia with Lewy bodies (DLB) [24] and in subjects with Huntington’s disease (HD) [25] suggesting a common pathogenic role.